The death of actor Philip Seymour Hoffman from an apparent heroin overdose has thrown a spotlight on the rise of heroin use in recent years. Melissa talks to John Venza, vice president at Outreach — a substance abuse treatment agency in New York and Long Island — about heroin addiction and the challenges to staying clean.
A new front has opened in the political battle over the Affordable Care Act, with Tuesday's release of the Congressional Budget Office's annual budget and economic outlook. The economists updated an earlier estimate about how many workers would leave the workforce because they no longer needed a job to have health care coverage — revising upward from 800,000 people to over 2 million people. Republicans pounced on the higher number, and President Obama now finds himself playing defense.
Originally published on Wed February 5, 2014 1:41 pm
Young people in their teens and early 20s probably aren't thinking about heart disease. But maybe it's time they did.
People who have slightly higher blood pressure when they're 18 to 25 are more likely to have high blood pressure and hardening of the arteries in their 40s, a study says. About one quarter of the people in this study were in that group.
Dr. Vivek Murthy, President Obama's nominee to be the next U.S. surgeon general, testifies Tuesday on Capitol Hill before the Senate Health, Education, Labor and Pensions Committee hearing on his nomination.
Originally published on Wed February 5, 2014 10:50 am
Boston physician Vivek Murthy was expected to run into political headwinds Tuesday during his Senate confirmation hearing for the post of the nation's top doc — surgeon general.
Murthy, 36, the founder of a national physicians group that worked to pass the Affordable Care Act, was seen by some as vulnerable to GOP attacks because of his political work, his youth and his less-than-a-lifetime of public health experience — not to mention a few impolitic tweets guaranteed to rile conservatives.
The National Institutes of Health is teaming up with major drug companies in a new effort to identify disease-related molecules and biological processes that could lead to future medicines.
The public-private partnership is called AMP, for the "Accelerating Medicines Partnership," and it will focus first on Alzheimer's disease, Type 2 diabetes, and two autoimmune disorders: rheumatoid arthritis and lupus.